ArticleOpen forum infectious diseases2025
Risk and Distribution of Metastatic Infections by Primary Infection Focus in
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The role of dental assessment in source identification duringFrontiers in oral health · 2026Review
- Time to initial glycopeptide therapy and 30-day mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: This retrospective cohort study analyzed 1725 patients diagnosed with SAB. We assessed the incidence and distribution of metastatic infections within the cohort, stratifying the data by the timing postdiagnosis and the primary infection focus. Results: In the cohort of 1725 patients, 289 (16.7%) experienced a total of 439 metastatic infection events within the 90-day follow-up period. The majority of metastatic infections (approximately 85%) occurred within the first 7 days following diagnosis. The incidence of metastatic infections varied significantly with the primary focus of SAB, being highest in patients with endocarditis at 73.4%. The lung was the most frequent metastatic site (23.7%), followed by bones and joints (16.8%) and the central nervous system (12.3%). The distribution of metastatic sites significantly differed according to the primary infection focus. Conclusions: Our study findings provide essential insights into the risk and distribution of metastatic infections in patients with SAB, highlighting the critical role of the timing and primary infection focus. These findings enable healthcare professionals to adopt a more proactive and targeted approach to managing patients with SAB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.